Abstract
The administration of bioactive agents through IV can lead to serious complications, including partial-or full-thickness skin loss, infection, nerve and tendon damage, or loss of limb. Children's Hospital of The King's Daughters (CHKD) implemented a protocol to uniformity identify and treat infiltrates in order to avoid these serious potential complications.
MeSH terms
-
Antidotes / therapeutic use*
-
Clinical Protocols*
-
Extravasation of Diagnostic and Therapeutic Materials / nursing*
-
Humans
-
Hyaluronoglucosaminidase / therapeutic use
-
Infant, Newborn
-
Infant, Premature
-
Nitroglycerin / therapeutic use
-
Phentolamine / therapeutic use
-
Skin Diseases / chemically induced
-
Skin Diseases / nursing
Substances
-
Antidotes
-
Hyaluronoglucosaminidase
-
Nitroglycerin
-
Phentolamine